Document is current
Any future updates will be listed below
-
Authors
Argente, Jesús https://orcid.org/0000-0001-5826-0276
Clément, Karine https://orcid.org/0000-0002-2489-3355
Duis, Jessica https://orcid.org/0000-0001-6605-1028
Farooqi, I. Sadaf https://orcid.org/0000-0001-7609-3504
Kühnen, Peter https://orcid.org/0000-0003-0211-176X
Miller, Jennifer L. https://orcid.org/0000-0003-4370-3438
Roth, Christian L. https://orcid.org/0000-0003-3037-4057
van den Akker, Erica https://orcid.org/0000-0001-5352-9328
- License Information
-
More Information
Article History
Accepted: 17 June 2025
First Online: 25 June 2025
Declarations
:
: Not applicable.
: Not applicable.
: JA received compensation for lectures and the BBS advisory board from Rhythm Pharmaceuticals, Inc. KC is a primary investigator for Rhythm Pharmaceuticals, Inc., and her research group has received research support from Rhythm Pharmaceuticals, Inc. JD is employed by Neurocrine Biosciences. The opinions in this manuscript are her own. ISF received compensation for lectures from Rhythm Pharmaceuticals, Inc. and led trials funded by Rhythm Pharmaceuticals, Inc. and Eli Lilly. JLM has received study funding from Rhythm Pharmaceuticals, Inc., Soleno Therapeutics, and Harmony Biosciences. PK has participated on a safety board for and their institution has received funding for clinical trial research from Rhythm Pharmaceuticals, Inc. CLR’s institution has received research support from Rhythm Pharmaceuticals, Inc. EvdA’s institution received compensation for writing and presentations from Federatie Medisch Specialisten, Medialane TV, Pfizer, and Stichting Kwaliteitsgelden Medisch Specialisten and study funding from Nederlandse Hartstichting/ZonMW, Rhythm Pharmaceuticals, Inc., and Stichting Erasmus Trustfonds.
